Pacira BioSciences, Inc.(PCRX)

Sector:

Healthcare

Description:

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Current Price

$39.09

RSI

42.43

Market Capitalization:

2.5B

Beta:

0.842

Volume:

379,836

Analyst Target Price:

$ 75.8

Economiic Fair Price:


November 03, 2022
November 03, 2022
Q3
N/A
N/A
N/A
N/A
N/A
0.82
6.39 %
13.69
0.0544

27.59 %
-74.29 %
586.18 %
31.12 %
-91.46 %
-20.63 %

$ 541.5M
26.04 %
$ 429.6M
2.05 %
$ 421M
24.83 %
$ 337.3M
17.67 %
$ 286.6M
3.71 %
$ 276.4M

$ 79.9M
103.54 %
$ 39.2M
-35.01 %
$ 60.4M
75.69 %
$ 34.4M
2419.78 %
$ -1.5M
-116.94 %
$ 8.7M

$ 56.4M
180.77 %
$ 20.1M
286.91 %
$ -10.7M
-2428.94 %
$ -425K
99.00 %
$ -42.5M
-12.23 %
$ -37.8M

News

Press Releases

Notable Dates